Bristol-Myers Squibb Completes Acquisition of IFM Therapeutics
Bristol-Myers Squibb Company announced that it has completed the previously announced planned acquisition of IFM Therapeutics.
The transaction includes full rights to IFM’s…
Read More...
Read More...
